Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions.
Mercadal S, Sancho JM, Climent F, Tapia G, Pomares H, Carro I, Sorigué M, Pané M, Domingo-Doménech E, Encuentra M, Aguilera C, Oliveira AC, Andrade M, Fernández de Sevilla A, Ribera JM, González-Barca E, Sureda A. Mercadal S, et al. Among authors: tapia g. Eur J Haematol. 2020 Mar;104(3):198-206. doi: 10.1111/ejh.13359. Epub 2019 Dec 22. Eur J Haematol. 2020. PMID: 31769545
The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment.
Sancho JM, García O, Mercadal S, Pomares H, Fernández-Alvarez R, González-Barca E, Tapia G, González-García E, Moreno M, Domingo-Domènech E, Sorigué M, Navarro JT, Motlló C, Fernández-de-Sevilla A, Feliu E, Ribera JM. Sancho JM, et al. Among authors: tapia g. Leuk Res. 2015 Aug;39(8):853-8. doi: 10.1016/j.leukres.2015.05.009. Epub 2015 May 28. Leuk Res. 2015. PMID: 26122511
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.
Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol AM, Montoto S, Gribben JG, Calaminici M, Martinez A, Gonzalez-Farre B, Dlouhy I, González-Barca E, Terol MJ, Miralles P, Alcoceba M, Vall-Llovera F, Briones J, Abrisqueta P, Abella E, Provencio M, García-Ballesteros C, Moraleda JM, Sancho JM, Ribera JM, Mate JL, Navarro JT. Baptista MJ, et al. Among authors: tapia g. Leuk Lymphoma. 2019 Apr;60(4):1087-1091. doi: 10.1080/10428194.2018.1512711. Epub 2018 Oct 15. Leuk Lymphoma. 2019. PMID: 30322315 No abstract available.
Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma.
Sorigue M, Bishton M, Domingo-Domenech E, McMillan A, Prusila R, García O, Kuusisto M, Condom M, Tapia G, Ribera JM, Kuittinen O, Fox CP, Sancho JM. Sorigue M, et al. Among authors: tapia g. Leuk Lymphoma. 2019 Oct;60(10):2524-2531. doi: 10.1080/10428194.2019.1594212. Epub 2019 Apr 3. Leuk Lymphoma. 2019. PMID: 30942640
297 results